OVATIO CRT and SITUS OTW LV Lead Post Approval Study

NCT00795873 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2260

Last updated 2013-09-18

No results posted yet for this study

Summary

Post approval study measuring safety outcomes on the Ovatio CRT-D and SITUS OTW LV lead over 5 years.

Conditions

Sponsors & Collaborators

  • ELA Medical, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00795873 on ClinicalTrials.gov